Skip to main content
    S

    Sensei Biotherapeutics Inc (SNSE)

    Official site

    BIOTECHNOLOGY

    $13.85
    +0.85 (+6.54%)

    Last updated: Jun 15, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(12/22)
    Avg Surprise
    -1097.01%

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$-5.45
    Range$-10.07 - $-0.98
    4 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$-0.67-712.8%
    7d ago$-3.90-39.5%
    Current$-5.45
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    Period ending Sep 30, 2026
    EPS Consensus$-5.67
    Range$-10.44 - $-1.00
    4 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$-0.72-687.4%
    7d ago$-4.08-39.0%
    Current$-5.67
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    Last 12 of 23 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-92.57$-149.27 - $-8.35--4--
    Sep 26EST
    		-$-5.67$-10.44 - $-1.00--4
    No revisions (30d)
    		-
    Jun 26EST
    		-$-5.45$-10.07 - $-0.98--4
    No revisions (30d)
    		-
    Mar 26
    Reported May 15
    		$-131.45$-0.62$-0.62 - $-0.62-21101.61%Miss1
    No revisions (30d)
    		-48138.5%
    Dec 25
    Reported Mar 30
    		$-3.74$-4.81$-4.81 - $-4.81+22.25%Beat1
    2
    0
    30d
    		-1271.0%
    Sep 25
    Reported Nov 14
    		$-3.62$-0.23$-0.23 - $-0.23-1473.91%Miss1
    2
    0
    30d
    		-1148.3%
    Jun 25
    Reported Aug 5
    		$-3.91$-0.24$-0.24 - $-0.24-1529.17%Miss1
    0
    1
    30d
    		-1296.4%
    Mar 25
    Reported May 6
    		$-0.27$-0.26$-0.26 - $-0.26-4.81%Miss1
    1
    0
    30d
    		+14.8%
    Dec 24
    Reported Mar 28
    		$-0.27$-0.29$-0.29 - $-0.29+5.93%Beat1
    0
    1
    30d
    		+9.1%
    Sep 24
    Reported Nov 14
    		$-0.29$-0.31$-0.33 - $-0.31+6.45%Beat3
    1
    1
    30d
    		-3.6%
    Jun 24
    Reported Aug 6
    		$-0.28$-0.29$-0.33 - $-0.16+3.45%Beat4
    No revisions (30d)
    		+9.7%
    Mar 24
    Reported May 9
    		$-0.32$-0.28$-0.31 - $-0.24-14.29%Miss3
    No revisions (30d)
    		+3.0%
    Dec 23
    Reported Feb 28
    		$-0.30$-0.31$-0.32 - $-0.29+3.23%Beat3
    No revisions (30d)
    		+25.0%
    Sep 23
    Reported Nov 7
    		$-0.28$-0.34$-0.40 - $-0.28+17.65%Beat2
    No revisions (30d)
    		+36.4%
    Jun 23
    Reported Aug 3
    		$-0.31$-0.33$-0.34 - $-0.32+6.06%Beat2
    No revisions (30d)
    		+8.8%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$13.79
    SMA 20$15.96
    SMA 50$23.03
    SMA 200$16.29
    EMA 10$13.96
    EMA 20$16.12
    EMA 50$20.17
    EMA 200$17.73

    MACD

    Line: -2.91Signal: -2.88Hist: -0.03

    ADX

    ADX: 26.2+DI: 18.6-DI: 24.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down92.0
    PSAR$10.78

    Bollinger Bands

    Upper Band$21.62
    Lower Band$10.29
    %B Position7098%(Upper)
    Band Width0.31

    RSI (14-Day)

    Neutral
    38.8

    Momentum Oscillators

    Stoch %K16.5
    Stoch %D8.6
    Williams %R-71.4
    ROC (10d)-30.0%
    Momentum-5.94
    CCI (20d)-48.9
    MFI (14d)42.6

    Volatility Measures

    ATR (14d)$2.68(19.3%)
    StdDev (20d)2.83
    Hist Vol163.2%(High)

    Volume Flow

    VWAP$14.71
    OBV10.6M
    AD Line1.5B
    CMF (20d)-0.433

    Volume Metrics

    Avg Vol (20d)56.0K
    Vol Ratio3.9x(High)
    VWMA (20d)$15.48

    Pivot Points

    R3$15.87
    R2$14.49
    R1$13.75
    Pivot Point$12.37
    S1$11.63
    S2$10.25
    S3$9.51

    Advanced Oscillators

    TSI-34.13
    Ultimate Osc30.0
    KST-394.85

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$0$0$-4,851,000$0$0$544,000$0$0$0$2.85M$0$0
    Cost of Revenue$132.96M$4.78M$-4,851,000$37,000$30,000$139,000$140,000$135,000$137,000$135,000$455,000$491,000
    Gross Profit$-132,957,000$67,000N/A$-37,000$-30,000$-139,000$-140,000$-135,000$-137,000$-135,000$-455,000$-491,000
    Operating Expenses$37.67M$4.96M$4.85M$5.21M$7.27M$7.18M$7.68M$7.65M$8.59M$8.01M$7.28M$9.69M
    R&D$17.96M$2.17M$2.54M$2.53M$3.73M$4.49M$4.64M$4.58M$4.92M$4.49M$3.82M$4.48M
    SG&A$19.71M$2.79M$2.31M$2.67M$3.55M$2.83M$3.19M$3.20M$3.81M$3.65M$3.92M$5.39M
    Operating Income$-170,627,000$-4,957,000$-4,851,000$-5,206,000$-7,274,000$-7,323,000$-7,823,000$-7,787,000$-8,730,000$-8,141,999$-7,737,000$-10,185,000
    Interest Income$392,000$223,000$289,000$321,000$405,000$522,000$591,000$669,000$768,000$826,000$877,000$952,000
    Interest Expense$0$3,000$6,000$10,000$13,000$17,000$21,000$24,000$28,000$31,000$33,000$38,000
    Income Before Tax$-170,236,000$-4,717,000$-4,569,000$-4,936,000$-6,864,000$-7,770,000$-7,253,000$-7,142,000$-7,992,000$-7,414,000$-7,124,000$-9,386,000
    Income Tax Expense$0$0$0$0$0$0$0$0$93,724$1.46M$-332,000$106,000
    Net Income$-170,236,000$-4,717,000$-4,569,000$-4,936,000$-6,864,000$-7,770,000$-7,253,000$-7,142,000$-7,992,000$-7,414,000$-7,124,000$-9,386,000
    EBITDA$-170,236,000$-4,680,000$-4,529,000$-4,889,000$-6,817,000$-7,614,000$-7,092,000$-6,983,000$-7,827,000$-7,247,999$-6,636,000$-8,857,000
    EBITN/A$-4,714,000$-4,563,000$-4,926,000$-6,851,000$-7,753,000$-7,232,000$-7,118,000$-7,964,000$-7,382,999$-7,091,000$-9,348,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SNSE

    News

    No news available

    Company news will appear here when available

    SNSE Competitors

    CompanyTicker
    Picard Medical, Inc.PMI
    Estrella Immunopharma Inc.ESLA
    Vyne Therapeutics IncVYNE
    Pasithea Therapeutics CorpKTTA
    Cocrystal Pharma IncCOCP
    Context Therapeutics IncCNTX
    Quoin Pharmaceuticals Ltd DRCQNRX
    Jasper Therapeutics IncJSPR

    Sector: Healthcare

    SNSE Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -424.3%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $-5.45
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    0 up, 0 down

    SNSE ETF Holders

    GNG tracks 1 ETF that holds SNSE.

    1. Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
    Open the ETF Stock Exposure tool for SNSE

    See insider activity

    Frequently Asked Questions About SNSE

    Does SNSE pay dividends?

    Sensei Biotherapeutics Inc (SNSE) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In